Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

NRX.V Relative to the S&P 500

Seasonal Chart Analysis

Analysis of the NurExone Biologic Inc. (TSXV:NRX.V) seasonal charts above shows that a Buy Date of January 29 and a Sell Date of June 26 has resulted in a geometric average return of 35.24% above the benchmark rate of the S&P 500 Total Return Index over the past 13 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 13 years by an average of 34.29% per year.

NurExone Biologic, Inc. is a pharmaceutical company, which engages in the development and commercialization of biological extracellular vesicles-based technology drug platforms. It focuses on the treatment of spinal cord injury, traumatic brain injury, and other brain and neurological indications. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.

To download NRX.V seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: NRX.V